Clinical Trial Update: Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment

View source ↗

Summary

This clinical trial update examines retention rates for three antiepileptic drugs—topiramate, levetiracetam, and oxcarbazepine—in long-term epilepsy treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Keppra (levetiracetam)
• TRILEPTAL (OXCARBAZEPINE)
• Topamax (Topiramate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Epilepsy | Status: UNKNOWN